Skip to main content
Total Market Cap: $122,027,944,242 Volume (24h): $9,517,451,054

Canntab Therapeutics Limited

Canntab Therapeutics Limited (PILL) logo
Rank 112
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Website
$0.7555
USD
1.05%
Market cap
$26,784,269
Total volume
$21,584
Shares outstanding
35,451,437
Reserved shares
16,510,036
Rank 112
Website
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
The Canadian Securities Exchange
CSE
PILL
$18,774
86.98%
$0.7555
OTC
CTABF
Total volume
$2,810
13.02%
Stock price
$0.6160
Chart
Social media
Tweets by @@Canntab_
Canntab Therapeutics Limited

Share widget

Copy widget code
Subscribe to our newsletter